Skip to Main Content

Paper Details

Comparative Pricing of Branded Tenofovir Alafenamide-Emtricitabine Relative to Generic Tenofovir Disoproxil Fumarate-Emtricitabine for HIV Preexposure Prophylaxis: A Cost-Effectiveness Analysis.
Ann Intern Med
26
2020
ESRD, Emtricitabine, F, F/TAF, HIV, TAF, TDF, Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, Tenofovir alafenamide, emtricitabine, end-stage renal disease, fractures, men, person, persons, tenofovir disoproxil fumarate
Author NameAffiliation
Rochelle P WalenskyMassachusetts General Hospital, Harvard University Center for AIDS Research, Harvard Medical School
Kenneth A FreedbergMassachusetts General Hospital and Harvard University Center for AIDS Research, Harvard Medical School
Ari PaltielYale School of Public Health
  • 1 - 3

Datasets

Release 1.2